NYSE Opposition to Trading-Fee Review Puts Companies and Some Shareholders at Odds

Wall Street Journal July 11, 2018 — The New York Stock Exchange is stirring tension between some of its big listed companies and their largest investors over regulators’ efforts to study the controversial practice of assigning fees and rebates to stock trades. In the story, Tyler Gellasch Executive Director of Healthy Markets says “Corporate issuers are being put in a terrible position,” “Do I side with my listing exchange or my largest investors?”

Read more in the Wall Street Journal.

Reader Interactions